1 2 5 7 a r t i c l e s Polycomb group proteins have important roles in regulating embryonic development 1,2 and have been implicated in embryonic stem cell pluripotency [3] [4] [5] [6] [7] . The two Polycomb complexes, PRC1 and PRC2, have been characterized in depth. The PRC2 complex trimethylates histone H3 Lys27 (H3K27me3) 8 , providing a docking site for proteins with a chromobox (Cbx) domain 9 . Proteins in the Cbx family are subunits of the PRC1 complex, and they facilitate PRC1 recruitment to target genes. The two complexes can silence genes either synergistically or independently of each other. Thus, regulation of H3K27 methylation represents an essential step in gene regulation by Polycomb proteins. In flies, the Polycomb complexes are recruited to chromatin at the Polycomb responsive elements (PRE). Although a few mammalian PRE sequences have been identified 10, 11 , it is still unclear how Polycomb group proteins are recruited to genome loci. Recent data suggest that mammalian PRC2 preferentially binds to CpG islands 12 . Moreover, long noncoding RNAs and transcription factors have also been implicated in modulating Polycomb group protein occupancy 13 . Among those, Jarid2 has been implicated in regulating the binding of the PRC2 complex to genomic targets in mouse embryonic stem (mES) cells; however, there are likely to be other mechanisms for fine-tuning [14] [15] [16] [17] . For example, in Drosophila melanogaster, the Polycomb-like protein (Pcl) associates with PRC2 and is required for global H3K27 trimethylation 18, 19 . A role for Polycomb-like proteins in regulating H3K27 trimethylation seems to be conserved in higher vertebrates [20] [21] [22] [23] . Notably, all members of the human PCL family of proteins (Phf1, MTF2 and Phf19) contain several domains that have been implicated in recognizing methylated histone residues.
Polycomb group proteins have important roles in regulating embryonic development 1,2 and have been implicated in embryonic stem cell pluripotency [3] [4] [5] [6] [7] . The two Polycomb complexes, PRC1 and PRC2, have been characterized in depth. The PRC2 complex trimethylates histone H3 Lys27 (H3K27me3) 8 , providing a docking site for proteins with a chromobox (Cbx) domain 9 . Proteins in the Cbx family are subunits of the PRC1 complex, and they facilitate PRC1 recruitment to target genes. The two complexes can silence genes either synergistically or independently of each other. Thus, regulation of H3K27 methylation represents an essential step in gene regulation by Polycomb proteins. In flies, the Polycomb complexes are recruited to chromatin at the Polycomb responsive elements (PRE). Although a few mammalian PRE sequences have been identified 10, 11 , it is still unclear how Polycomb group proteins are recruited to genome loci. Recent data suggest that mammalian PRC2 preferentially binds to CpG islands 12 . Moreover, long noncoding RNAs and transcription factors have also been implicated in modulating Polycomb group protein occupancy 13 . Among those, Jarid2 has been implicated in regulating the binding of the PRC2 complex to genomic targets in mouse embryonic stem (mES) cells; however, there are likely to be other mechanisms for fine-tuning [14] [15] [16] [17] . For example, in Drosophila melanogaster, the Polycomb-like protein (Pcl) associates with PRC2 and is required for global H3K27 trimethylation 18, 19 . A role for Polycomb-like proteins in regulating H3K27 trimethylation seems to be conserved in higher vertebrates [20] [21] [22] [23] . Notably, all members of the human PCL family of proteins (Phf1, MTF2
and Phf19) contain several domains that have been implicated in recognizing methylated histone residues.
In this study, we have investigated the role of Phf19 in regulating PRC2 activity in mES cells. We report that Phf19 is associated with PRC2 proteins in a complex lacking Jarid2. Biophysical and structural data show that the Tudor domain of Phf19 binds with high affinity to methylated H3K36, a characteristic shared by all members of the PCL family. Depletion of Phf19 caused a global reduction of H3K27me3 and impaired the occupancy of PRC2 complex genomewide. We observed similar effects in cells ectopically expressing Phf19 carrying a point mutation in its Tudor domain. Phf19 knockdown ES cells showed loss of pluripotency and defects in differentiation. Mechanistically, we further show that Phf19 has a pivotal role in silencing active promoters by directly targeting the PRC2 complex and H3K36 histone demethylases. Our data indicate that Phf19 is an important regulator of PRC2 function in mES cells. chromodomain' . Notably, the α-helix seems to be conserved among Mtf2, Phf19 and the D. melanogaster homolog Pcl, but it was not predicted for Phf1.
Phf19's Tudor domain binds to di- and trimethylated H3K36
To determine the domains necessary for regulating PRC2 activity at chromatin, we tested the purified, recombinantly expressed Phf19 domains for binding to a histone peptide array 27 (Fig. 2a) . The Tudor domain of Phf19 bound to dimethylated (me2) and trimethylated (me3) H3K36, but not to numerous other methylated peptides. Histone peptide pull-down assays confirmed the specificity of the interaction (Fig. 2b) .
We next asked whether the H3K36 interaction is conserved among proteins of this family, including the mammalian homologs Phf1 (Pcl1) and Mtf2 (Pcl2) and D. melanogaster Pcl. We found that the Tudor-H3K36 interaction is conserved among all proteins of the family, but D. melanogaster Pcl did not bind H3K36me2 or H3K36me3. Sequence comparison of the Tudor domain among the Pcl family members showed that several amino acids are conserved, including a set of aromatic residues (Supplementary Fig. 1a ). These amino acids commonly give rise to the conserved 'aromatic cage' that accommodates methylated histone residues. Notably, the Tudor domain of D. melanogaster Pcl lacks one of these aromatic residues and fails to bind methylated H3K36 as an isolated polypeptide ( Fig. 2b and Supplementary Fig. 1a ). In line with this, a recently published NMR structure of D. melanogaster Pcl reveals a lack of a well-defined cage in this protein 28 . Nevertheless, using a Pcl Tudor-PHD1 construct, we were able to rescue the binding to H3K36me2 and H3K36me3 (Fig. 2b) . Of note, none of the other Phf19 domains showed detectable binding to methylated H3K36.
Structural analysis of the Phf19 Tudor domain
We measured the binding of human PHF19-Tudor to an 11-mer H3K36me3-derived peptide (31-ATGGVKme3KPHRY-41) by npg a r t i c l e s NMR spectroscopy in 2D 15 N-1 H and 2D 13 C-1 H correlation spectra ( Fig. 3a and Supplementary Fig. 2) . Analysis of the ligand concentration-dependent chemical shift changes gave a K d for the complex of 29 µM (Fig. 3b) Fig. 2 ). Titration of Phf19-Tudor with the peptide (31-ATGGVKKPHRY-41), as well as surface plasmon resonance and pull-down assays with peptides with H3K36 or a modified H3K36me1, H3K36me2 or H3K36me3 residue, showed no substantial binding for unmodified or monomethylated peptides, but peptides with either di-or trimethylated H3K36 supported the interaction ( Fig.2b and Supplementary Fig. 3a,b) . Indeed, NMR analysis with H3K36me2-containing peptide indicated a K d for the complex of 295 µM (Supplementary Fig. 3c,d ), one-tenth as strong as binding of the H3K36me3 peptide (K d = 29 µM).
To gain insight into the specificity of the interaction between Phf19-Tudor and the H3K36me3 histone tail, we solved the solution structure of the complex by NMR ( Table 1) . A detailed description of the structure determination and data statistics is found in the supporting online material. Phf19-Tudor contains five antiparallel β-sheets, which form the characteristic β-barrel. Trimethyllysine is inserted into a deep hydrophobic pocket, formed by the aromatic cage residues Trp50 (β1-β2 loop), Tyr56 (β1), Phe74 (β3) and Tyr80 (β4), with Val82 (β4) delineating the bottom of the pocket (Fig. 3c) . In agreement with this, the W50A, Y56A, F74A and Y80A mutants were unable to bind the H3K36me3 peptide (Supplementary Fig. 3e ). The trimethyllysine residue was recognized by a classical π-cation interaction, aided by additional hydrophobic contacts with the floor of the pocket (Val82) and coulombic interactions with the negatively charged residues at the edge of the pocket (Asp76 and Ser78 from the β3-β4 loop). Additional negatively charged side chains (Glu75 from the same loop, and Thr51 and Asp52 from the β1-β2 loop) surround the pocket entry site (Fig. 3c,d ) and compensate for the positive charge of the peptide. The mutant D52R did not bind the H3K36me3 peptide, either because of strong coulombic repulsion with the positively charged peptide or because of partial occlusion of the methyllysine-binding pocket by the long arginine side chain.
The peptide exists in an extended conformation, as is often observed for other complexes involving histone tails (see also Supplementary Note) 29, 31, 33, 34, 37 . The C-terminal half of the peptide interacts firmly with the Tudor domain, whereas the histone H3 residues 31-34 do not show any NOE connectivities to the protein. Accordingly, a peptide lacking the C-terminal part but containing the trimethyllysine (H3 [31] [32] [33] [34] [35] [36] ) was unable to bind Phf19-Tudor, whereas the 7-mer peptide histone H3 [35] [36] [37] [38] [39] [40] [41] had a similar affinity to the 11-mer histone H3 [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] peptide (K d = 44 µM, Fig. 3b) . Thus, the specificity of Phf19-Tudor for the H3K36me3 histone tail resides in the amino acid sequence following the methylated lysine. The side chain of H3K37, which lies next to H3K36me3, is involved in electrostatic interactions with the side chain of Phf19-Tudor residue Glu75. The rest of the peptide (H3 Pro38-Tyr41) fits snugly to a hydrophobic surface consisting of β1 residue Leu47, β2 residues Leu54, Tyr55, Tyr56 and Leu57, and the C-terminal residue Gln88. H3 Pro38 packs neatly against the side chain of Tyr56 and Leu54, whereas H3 His39 contacts both Leu47 and Leu57. Accordingly, the methyl resonances of Leu47 show a prominent chemical shift change upon binding the peptide, and several NOE connectivities to both H3 His39 and H3 Tyr41 ( Supplementary  Fig. 2b ). H3 Arg340 points away from the protein, whereas H3 Tyr41 interacts with Leu47, Tyr55 and possibly Gln88. Although we observed no NOE connectivities between H3 Tyr41 and Gln88, the chemical shift change of the Gln88-Hβs upon peptide binding supports this interaction. The H N of H3 His39 is close to the carbonyl of Tyr55 in most structures of the ensemble and could further stabilize the complex by an intermolecular hydrogen bond.
We confirmed this network of intermolecular interactions by inserting point mutations into histone H3 at amino acids 37-41. Using NMR, we measured the K d of the complex with Phf19-Tudor for each of these alanine mutants (Fig. 3b) . The H3 R10A mutation did not increase the complex K d , in agreement with the idea that its side chain is directed toward the solvent. In contrast, we observed the a b The network of interactions seen in the complex structure provides a rationale for the selectivity of the Phf19 Tudor domain for the H3K36me histone tail, as observed in the peptide array (Fig. 2a) . H3K36me3 uniquely contains a long positively charged side chain (Lys37) and two bulky hydrophobic side chains at the +1, +3 and +5 position from the trimethyllysine, respectively. A positively charged amino acid occupies position +1 from the methyllysine in only three histone-derived peptides, H3K36me3, H2AK75me3 and H2BK23me3 (Supplementary Fig. 1b) . However, neither H2AK75me3 nor H2BK23me3 have bulky hydrophobic side chains at either the +3 or +5 position.
Phf19 colocalizes with PRC2 and regulates its occupancy
To investigate the physiological link between H3K36 methylation, Phf19 and PRC2, we first analyzed the expression profile of Phf19 during mES cell differentiation. Phf19 expression is downregulated after induction of differentiation by treatment with retinoic acid (Supplementary Fig. 4a ). This pointed toward a potential role for Phf19 in both mES cell self-renewal and differentiation mechanisms. To identify direct target genes of Phf19 in mES cells, we performed chromatin immunoprecipitation followed by highthroughput sequencing (ChIP-seq). We identified 2,334 Phf19 target genes with peaks mostly found in close vicinity to the transcription start site (Fig. 4a, Supplementary Fig. 4b and Supplementary  Table 1) . Consistent with the finding that Phf19 associates with PRC2, 85% of Phf19 target genes were also bound by the PRC2 subunit Suz12, the vast majority of which were also decorated with H3K27me3 (Fig. 4b,c) . In line with being Polycomb targets, gene ontology analysis revealed that many genes encoded signaling molecules and transcription factors required for embryonic development that are normally repressed in mES cells (Fig. 4d) . We validated the ChIP-seq results and the specificity of the Phf19 antibody by performing ChIP-qPCR in control cells (shRandom) and cells knocked down for Phf19 (shPhf19). Target genes obtained from the ChIP-seq analysis were also bound in control cells, but knockdown (Fig. 4e and  Supplementary Fig. 4a) . Notably, the occupancy of Phf19 was substantially reduced in differentiated mES cells (Fig. 4f ) , consistent with its downregulation upon retinoic acid-induced differentiation of ES cells (retinoic acid treatment 72 h). We then asked whether an intact PRC2 is required for Phf19 to bind to chromatin. To this end, we performed ChIP-qPCR in cells in which Eed, a core subunit of the PRC2 (ref. 38) , is deleted (Eed −/− ). Binding of Phf19 to target genes was almost entirely absent in these cells, suggesting that Phf19 binds to target genes as an integral component of PRC2 (Fig. 4g) . To test whether Phf19 is required for PRC2 binding to target genes, we looked at genome-wide H3K27me3 and PRC2 subunits in cells following Phf19 knockdown. Compared to control cells, Phf19 knockdown cells showed a substantial reduction of Suz12 levels in 82% of the Phf19, Suz12 and H3K27me3 co-targets. Moreover, 71% of the target genes completely lost their H3K27me3 mark upon Phf19 depletion (Fig. 5a,b) . However, in contrast to the effect on the core subunits of PRC2 (ref. 39), knockdown of Phf19 did not affect the protein levels of PRC2 components or the stability of the PRC2 complex ( Supplementary Fig. 4c ).
Overall, these results confirm that Phf19 binds to target genes only in the context of an intact PRC2 and that it is required for a stable association of PRC2 at target genes. In line with this, we observed a global reduction of H3K27me3 in three independent Phf19 knockdown cell lines, with a corresponding increase of H3K27me1 and acetylated H3K27 (H3K27ac, Fig. 5c ).
These data are in good agreement with the phenotype observed upon loss of Pcl in D. melanogaster, as well as that observed with deletion of Phf1 (Pcl1) in mammals 18, 22, 23 . Of note, it has been recently shown that the loss of Mtf2 (Pcl2) in mES cells leads to enhanced pluripotency and to sustained levels of H3K27me3, suggesting functional diversification among members of the Pcl family 21 .
Role of Phf19 in mES cell self-renewal and differentiation
Global mRNA expression analysis using microarrays showed that an approximately equal number of genes were upregulated and downregulated upon depletion of Phf19 (Fig. 6a,b and Supplementary Table 2) . Of the upregulated genes, 20% were direct Phf19 targets and 44% were PRC2 targets, as determined by Suz12 occupancy ( Supplementary  Fig. 4d,e) . As expected, gene ontology annotation showed that the 
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Phf19-depleted embryoid bodies showed a differentiation delay, as indicated by the sustained expression of early-differentiation markers for ectoderm (Fgf5) and mesoderm (Brachyury/T) lineages (Supplementary Fig. 4h ). When subcutaneously injected into immunodeficient mice, Phf19-depleted cells produced teratomas that contained tissues representative of the three germ layers, with an overrepresentation of ectoderm tissues ( Supplementary Fig. 5a-c) . Indeed, analysis of the gene expression profile comparing wild-type and Phf19-knockdown mES cells (Fig. 6a) indicated that several ectoderm and trophoectoderm markers were upregulated, whereas endoderm and mesoderm markers were either unaffected or downregulated (Supplementary Fig. 5d) . Notably, the sizes of the genes differentially expressed in the Phf19 knockdown are highly enriched in developmental regulators (Supplementary Fig. 4f) .
Notably, the cohort of downregulated genes in Phf19-knockdown ES cells included those encoding several pluripotency markers, such as Nanog and Klf4 (Fig. 6b) . In agreement with this, we observed a loss of pluripotency in Phf19-knockdown ES cells, as judged by the number of alkaline phosphatase-positive colonies ( Supplementary  Fig. 4g ). Although many cells remained alkaline phosphatase positive ( Supplementary Fig. 4g, above) , a small but substantial number of them became alkaline phosphatase negative upon knockdown of Phf19 (Supplementary Fig. 4g, below) .
We next investigated whether Phf19 has a role during differentiation of mES cells into embryoid bodies. In Phf19-depleted embryoid bodies, we observed that the pluripotency markers (such as Oct4 and Nanog) were not completely silenced (Supplementary Fig. 4h ), in agreement with the role of Polycomb complexes in directly regulating repression of these genes during differentiation 9, 40 (Fig. 6c and Supplementary Fig. 5e ).
Phf19 facilitates re-silencing of transcribed genes
It has been recently shown that PRC2 enzymatic activity is inhibited by the presence of the H3K36me mark on mononucleosome substrates 8, 41 . This might prevent the spreading of repressive chromatin states to active promoters. The observation that loss of Phf19 leads to reduced H3K27me3 levels (Fig. 5c) prompted us to test whether the Tudor-H3K36me interaction might relieve the H3K36me2-and H3K36me3-dependent inhibition of PRC2 activity at Phf19 target promoters to facilitate re-silencing of transcribed genes. Unbiased analysis of Phf19-bound peaks showed an enrichment of H3K36me2 and H3K36me3 marks when compared to an equal number of random sequences. Validation of Phf19 targets confirmed an enrichment of H3K36me3 at the transcription start site (TSS) when compared to the corresponding 2-kb upstream regions (Supplementary Fig. 5f ).
The moderate genome-wide overlapping observed between Phf19 and the H3K36me2 and H3K36me3 marks suggested that H3K36me2 and H3K36me3 histone demethylases (KDMs) might be involved in Phf19-mediated gene silencing. We therefore analyzed the occupancy of several H3K36 KDMs at Phf19 target genes. We focused on the KDM4 family, which demethylate H3K9me3 and (with a much lower affinity) H3K36me3, and on the KDM2 family, which has been shown to demethylate H3K36me2 but could theoretically also act on H3K36me3 (ref. 42) . We found that KDM2b occupied several Phf19 target genes (Fig. 7a) . To get further insight into the mechanist links between Phf19, KDM2b and Polycomb complexes, we triggered ES cell differentiation with retinoic acid and investigated several promoters whose activity depends on Phf19. In all cases, retinoic acid administration led to promoter activation, a reduction in Polycomb occupancy concomitant with Phf19 and KDM2b displacement, and an accumulation of H3K36me2 and H3K36me3 marks. Notably, when Phf19 was knocked down in mES cells, the occupancy of KDM2b was also substantially reduced (data not shown). Together, these data suggest that KDM2b participates directly in regulating Phf19 target genes, although we cannot exclude the possibility that other KDMs might also have a role. Fig. 3e ) but still able to interact with the PRC2 complex ( Supplementary Fig. 5g-i) . ChIP analysis indicated that binding of endogenous Phf19 was diminished in knockdown cells; however, binding of tagged wild-type human Phf19 was detected in rescued cells and, to a lesser extent, in cells in which Tudor-mutated Phf19 was re-introduced (Fig. 7b) . Notably, the frequencies of PRC2 binding and H3K27me3 marks were substantially reduced in Phf19 knockdown cells. Re-expression of the human wildtype Phf19 in knockdown cells rescued PRC2 binding, the frequency of H3K27me3 marks and promoter silencing; in contrast, this rescue was not observed in cells expressing Tudor-mutated Phf19 (Fig. 7b,c) .
Together, these data suggest that Phf19 facilitates and/or stabilizes binding of PRC2 complex at H3K36-methylated promoters. Binding of the Phf19 Tudor domain to H3K36me2 and H3K36me3 might serve to overcome the allosteric inhibition of the PRC2 observed in vitro 8 , thus facilitating the recruitment of Polycomb proteins and of KDM2b, which in turn causes gene silencing.
DISCUSSION
In yeast, the H3K36me2 and H3K36me3 marks are implicated in recruiting a histone deacetylase-containing complex (Rpd3s) during RNA polymerase II-mediated transcription, which prevents aberrant transcription initiation within coding sequences. In higher eukaryotes, methylated H3K36 has been associated with active chromatin and with alternative splicing, but its potential roles in gene regulation and promoter silencing have so far been elusive 43 . Here we show that Phf19 binds to methylated H3K36 and recruits the PRC2 complex to promoters for silencing transcribed genes. Previously, it was reported that the PWWP domain of BRPF1 and the chromodomain of EAF3 (MRG15) bind specifically to methylated H3K36, but in both cases their affinity for H3K36me2 and H3K36me3 is much lower than that of Phf19-Tudor 37, 44 . Hence, Phf19-Tudor is by far the strongest and most specific recognition module for methylated H3K36. Our structural data confirm the amazing diversity in the binding modes of histone tails containing methyllysines. This diversity revolves around the trimethyllysine recognition motif (the aromatic cage), which provides a conserved anchor (Supplementary Figs. 6 and 7) . Furthermore, an assorted ensemble of intermolecular interactions around this anchor provides a means for specific recognition and regulation. Analysis of Phf19 targets indicated that the H3K36me2 and H3K36me3 marks were enriched at the TSS, although with a lower intensity when compared to the corresponding coding regions. The high affinity of Phf19-Tudor for H3K36me2 and H3K36me3 might therefore compensate for a reduced level of H3K36me2 and H3K36me3, whereas the specificity of binding at the TSS is likely to be provided by other domains of Phf19 for noncoding RNA molecules or for combinations of histone marks. Notably, all members of the mammalian Pcl family posses a conserved aromatic cage within the Tudor domain. Our in vitro experiments further support their ability to recognize methylated H3K36. Thus, it seems that all mammalian PCL proteins have a pivotal role in silencing active promoters by directly targeting the PRC2 complex, although with different promoter specificity. In D. melanogaster, this function is likely to be performed by a dedicated transcription factor, because the fly Pcl-Tudor does not bind to methylated H3K36, nor to any of the histone modifications we tested.
Together with the PRC2 complex, Phf19 also recruits a specific demethylase for methylated H3K36, the KDM2b enzyme. In agreement with our data, it has been reported that KDM2b associates with Polycomb proteins 45 and is implicated in regulating senescence 46 , leukemia progression 47 and reprogramming 48 . The presence of PRC2 complex and KDM2b would ensure that promoter silencing is achieved by the deposition of repressive marks (such as H3K27me3), and removal of the H3K36 methylation marks, which are associated with activation (Fig. 7d) . We cannot exclude the possibility that other KDMs might also have a role.
There is a strong genome-wide overlap between Phf19 and PRC2, with 85% of Phf19 target genes being co-regulated by PRC2. Deletion of Eed in mES cells, which causes disassembly and degradation of the PRC2 proteins, led to a strong reduction of Phf19 occupancy to promoters. This suggests that a stable genome-wide occupancy of Phf19 is achieved only in the context of an intact PRC2 complex. Conversely, depletion of Phf19 in mES cells has a strong impact both on global levels of H3K27me3 and on PRC2 occupancy. Taken together, these data provide evidence for an intricate contribution of Phf19 and PRC2 core components to proper gene regulation, mES cell pluripotency and lineage choices.
This study thus unveils a previously unanticipated role of methylated H3K36 in modulating PRC2 function and promoter activity.
METHODS
Methods and any associated references are available in the online version of the paper. NMR experiments. NMR experiments were performed on Bruker Avance III 600 MHz and 800 MHz spectrometers equipped with HCN triple-resonance cryo-probes. Spectra were acquired at a temperature of 298 K. Protein backbone assignments for free Phf19-Tudor and the Phf19-Tudor-H3K36me3 peptide complex were obtained using a combination of triple resonance HNCA [50] [51] [52] , HNCACB 53, 54 and CBCA(CO)NH 55 experiments. Protein side chain resonances in both free Phf19-Tudor and the complex were assigned from (H)CCH-TOCSY and H(C)CH-TOCSY 51 spectra, and amide-detected (H)CC(CO)NH-TOCSY and H(CCCO)NH-TOCSY 56, 57 experiments. For the Phf19-Tudor-H3K36me3 peptide complex, (HB)CB(CD)HD and (HB)CB(CDCE)HE experiments 58 were performed to aid assignment of aromatic protein resonances.
Peptide resonances in the Phf19-Tudor-H3K36me3 peptide complex were assigned from double-12 C, 14 N-filtered 2D NOESY (τ m = 120 ms) and double-12 C, 14 N-filtered 2D TOCSY spectra 59 .
The binding of the peptides was monitored by simultaneous 2D 13 Analysis of the chemical shift index 60 and NOE cross-peak pattern allowed identification of secondary-structure elements. Distance constraints were collected from 3D 15 N-NOESY (τ m = 150 ms), 3D 13 C-edited NOESY (τ m = 130 ms), 3D 13 C-edited/ 12 C-filtered NOESY (τ m = 150 ms), aromatic 3D 13 C-HMQC-NOESY and double-12 C, 14 N-filtered 2D 1 H-1 H NOESY spectra in H 2 O and in D 2 O (τ m = 150 ms) 59 .
H/D experiments allowed us to detect amides involved in the formation of hydrogen bonds. The 2D 1 H-15 N HSQC spectra were recorded immediately after dissolving lyophilized samples in D 2 O. Data were processed with NMRPipe 61 and analyzed using NMRView 62 .
Structure calculation and refinement. The experimentally determined distance and dihedral angle restraints were applied in a simulated annealing protocol with CNS/ARIA1.2 (refs. 63,64) with modified annealing protocols 65 . All NOE connectivities were manually assigned and automatically calibrated using 8 iterations, calculating 20 structures in iterations 1-7 and 100 structures in iteration 8. In the spectra, we did not observe the NMR resonances of the Hε and the methyl hydrogens of the H3K36me3 residue. This is due to exchange broadening, as a consequence of the conformational exchange process between the bound and free form of the peptide in conjunction with the large ring-current shift imposed to the Hε and methyl hydrogens of bound H3K36me3 by the presence of the aromatic cage. In the absence of NOE connectivities between the H3K36me3 methyl hydrogens and the rest of the protein, H3K36me3 occupies the binding pocket of the aromatic cage, but its position is not well defined. To overcome this problem, we added four additional ambiguous interaction restraints between all aromatic carbons of the exchange-broadened residues Trp50, Tyr56, Phe74 and Tyr80 and the Nζ of H3K36me3 of 4.0 ± 1 Å, respectively. These nonexperimental restraints are justified by the large chemical shifts experienced by the aromatic side chains of Trp50, Tyr56, Phe74 and Tyr80, which clearly indicate their involvement in binding H3K36me3. The CNS E repel function was used to simulate van der Waals interactions with an energy constant of 25.0 kcal mol −1 Å −4 , using 'PROLSQ' van der Waals radii 66 . Distance restraints were used with a soft square-well potential, using an energy constant of 50 kcal mol −1 Å −2 .
